Clinical trial
Psilocybin for Major Depressive Disorder (MDD)
NCT06308653
Study timeline
Study start (actual)2024-03-13Date precision: day
Registry last updated2026-07-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Depressive Disorder, Majorunresolved
Interventions
Sponsors & collaborators
Usona Institutelead sponsor
Mapped research locations
Santa MonicaCalifornia, United States2New YorkNew York, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1BirminghamAlabama, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1DenverColorado, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06308653 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.